NIH Under Fire: Longtime Favorite of Congress – Wash Post / WSJ Sun, 27 Jun 2004 Under fire from Congress with evidence of NIH staff engaging in secret outside contracts and consultancies, NIH Director, Dr. Elias Zerhouni, turned a corner. He acknowledged the problem at a hearing (June 22) of…
Loren Mosher dissident psychiatrist obits Tue, 20 Jul 2004 The untimely death of Dr. Loren Mosher leaves a great vacuum in the mental health reform movement–as few psychiatrists have had the moral courage to stand up with their patients against the abuses wrought by the “unholy alliance” of psychiatry, Big…
FDA Standards – Good Enough for Government Work? Fri, 23 Sep 2005 An essay in The New England Journal of Medicine, by Jerry Avorn, M.D., professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, chalolenges FDA’s “minimalist” drug…
Corporate Culture of Denial Results in Preventable Deaths Fri, 7 Jan 2005 Failure to disclose the hazardous effects of Vioxx and Prozac are evidence of a corporate culture that has run amok. Uncovered company documents – some obtained through litigation, others unearthed by whistleblowers – reveal that the manufacturers knew…
Treating children as young as 4 for bipolar – WSJ Thu, 26 May 2005 A report in The Wall Street Journal should raise serious concerns about the legitimacy of psychiatric diagnosing and drug prescribing for children. The Journal reports that close to 20,000 US children are being diagnosed with bi-polar…
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 10a, 2002 U.S. Bio-Tech Start-ups Conducting CheapPreliminary Studies in China FYI Harvard University is not the only one exploiting China’spoor population for medical experiments. Violations of…
Trial Lawyers Are Taking Aim at the Drug Industry_NYT Sun, 18 May 2003 It appears that trial lawyers will produce the results that government oversight agencies–in particular, the FDA–have failed to do. Namely, to protect the public against an increasing number of unsafe drugs. The pharmaceutical industry whose efforts to…
Antidepressant Controversy: Media Conflicts of Interest – New York Times Thu, 25 Mar 2004 FDA’s advisory warning about antidepressant drugs received wide press coverage nationally. But few in the national media mentioned conflicts of interest as the obstacle to disclosure of evidence showing these drugs’ adverse effects. Among the few…
Bayer drops legal action against Friends of the Earth re: Concealed pesticide data Fri, 2 Jul 2004 The Guardian reports that Bayer, the giant pesticide / pharmaceutical company has backed off from its bullying tactics in its effort to prevent Friends of the Earth from informing the public how to…
Practice Guidelines: Can We Trustthe Evidence in Evidence-Based Medicine? Sun, 25 Sep 2005 “Research and Clinical Practice Guidelines: Can We Trust the Evidence in Evidence-Based Medicine?” is an article by Dr. John Abramson* (Harvard) and Dr. Barbara Starfeld (Distinguished Professor, Johns Hopkins), published in the Journal of the American Board…
Lies & Broken Promises_Drug firm Websites Fail to Disclose Test Data Sun, 9 Jan 2005 One year after PhRMA’s publicized proclamation of its “commitment to transparency” The Boston Globe reviewed pharmaceutical company websites searching for disclosure of clinical trial data. The Globe found that this voluntary approach failed miserably: “Last…
FDA Smoke & Mirrors Musical Chairs Wed, 16 Feb 2005 Amidst widespread public criticism of the FDA’s role as facilitators in the marketing of lethal drugs that killed thousands of people, the Administration made several announcements incorporating terminology (such as: “we’re in an era of openness” “transparency”). But politically correct…
